This year analytica 2020, the largest trade show for lab technology, analysis, and biotechnology is going virtual! Analytica virtual will take place from October 19th to the 23rd, presenting hundreds of virtual booths, inspiring webinars and lectures available around the clock.
Eurofins Technologies will be participating with a virtual booth, along with 320 other companies in this exciting new format. We are looking forward to presenting our latest products and to connect with valuable business contacts.
We realize that a virtual fair does not allow a personal meeting or a hands-on experience with our products and instruments. However, the virtual booth frees you to explore our innovative solutions at your convenience. Explore our virtual booth, download our brochures, watch our product videos and send us a request for more information. Registration is free so sign up today at analytica virtual: free registration
Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces the launch of its SENSISpec Soy Total protein ELISA kit, an enzyme immunoassay for the quantitative detection of soy protein in food and swab samples.
The development of the assay has been performed by Eurofins Immunolab, a biotechnology company with a wide experience in food allergen analysis and part of Eurofins Technologies group.
Soy is one of the “Big Eight” allergens, along with cow’s milk, eggs, peanuts, tree nuts, wheat, fish, and shellfish. These are responsible for 90 percent of all food allergies, which in severe cases may lead to anaphylactic shock. Management of food allergies implies the elimination of the allergen from diet, requiring labeling and traceability throughout the food production process, from raw material to the final product.
Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of aflatoxin M1, I’screen AFLA M1 milk, has been granted AOAC Research Institute Performance Tested MethodsSM status (AOAC Cert. No. 072002) for use with raw bovine whole milk, skim milk and powdered milk.
Eurofins Technologies recently launched multiple serological assay solutions to detect antibodies targeted against the Nucleocapsid protein of the novel Coronavirus. Antibody tests can be used to identify individuals who have been previously exposed to the virus and in some cases those who have an active infection. However, simple presence of antibodies in an individual does not guarantee immunity to further infections since only a fraction of antibodies provide the ability to neutralize the virus upon a second contact. Currently, elaborate tests requiring high biological safety measures are required to identify these neutralizing antibodies.
Eurofins Technologies announces the launch of reagents for automated isolation of high-quality SARS-CoV-2 RNA (ribonucleic acid) from viral particles of human swab samples. The kits’ magnetic bead-based, automated testing method extracts and isolates virus particles and their respective RNA for subsequent real-time RT-PCR (reverse transcription polymerase chain reaction) analysis by IVD kits.
GSD NovaPrime® RNA Extraction AE1 and AE2 kits are validated for use with KingFisherTM Flex and MGI MGISP-960 automation platforms. Compatibility testing with several other open-platform extraction instruments is underway.
Eurofins Technologies announces the launch of CE-IVD marked rapid point-of-care testing devices to identify a person’s past exposure to COVID-19 (SARS-CoV-2) in only 10 minutes. The serology-based, finger-prick tests detect virus antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms.
Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of gluten, SENSISpec Ingezim Gluten R5, has been granted AOAC Research Institute Performance Tested MethodsSM status (AOAC Cert. No. 052005) for use with gluten-free bread, oat flour and stainless steel surfaces.
The assay was developed by Eurofins Ingenasa, a biotechnology company with more than 20 years of experience in food allergen analysis and a member of Eurofins Technologies’ group of companies.
Eurofins Technologies announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19. The development of the assay has been led by Eurofins Ingenasa, a Eurofins Technologies company involved in the development of diagnostic tests supporting the control of infectious diseases for over 35 years in veterinary and more recently in human diagnostics.
While molecular diagnostic techniques (PCR) are a direct indicator of the COVID-19 disease, serological tests determine whether a person has been exposed to the infection and has therefore developed antibodies to SARS-CoV-2.
Eurofins Technologies announces the launch of its CE-IVD marked multiplex Real-Time RT-PCR (reverse-transcriptase polymerase chain reaction) assay for the direct qualitative pathogen detection of the novel coronavirus (SARS-CoV-2). Particularly in the early phase of COVID-19 infection, the direct and precise diagnostic of the pathogen is key. PCR is the method of choice to detect acute coronavirus infections.
The development of the assay has been spearheaded by affiliate companies Gold Standard Diagnostics Inc., VIROTECH Diagnostics GmbH and NovaTec Immundiagnostica GmbH.
Eurofins GeneScan Technologies is offering a new kit as part of its VIRSeek Solution to detect SARS-CoV-2 (Coronavirus) in swabs of environmental surfaces.
Join our webinar to know more about our VIRSeek SARS-CoV-2 Coronavirus Environmental Testing Solutions!
Due to the SARS-CoV-2 virus’ potential for a prolonged tenacity on surfaces, transmission through contaminated surfaces is being investigated as a possible route of exposure. In the current coronavirus outbreak, companies and health authorities seek for solutions to monitor the presence of SARS-CoV-2 in their environments.